Combined factor V Leiden and prothrombin genotyping in patients presenting with thromboembolic episodes

Archives of Pathology and Laboratory Medicine

Volumn 125, Issue 1, 2001, Pages 105-111

  Friedline, J A ^a   Ahmad, E ^a   Garcia, D ^a   Blue, D ^a   Ceniza, N ^a   Mattson, J C ^a   Crisan, D ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

ADULT; AGE OF ONSET; AGED; FACTOR V; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTHROMBIN; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0035138717     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Epidemiology of pulmonary embolism and deep vein thrombosis
2. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT study
3. Deep vein thrombosis
4. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk
5. Mutation in blood coagulation factor V associated with resistance to activated protein C
6. Inherited thrombophilia due to Factor V Leiden mutation
7. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C
8. 506 to Gln mutation in the Factor V gene, and venous thrombosis: Functional tests and DNA-based assays, pros and cons
9. A common genetic variation in the 3′-unstranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
10. The Leiden Thrombophilia Study (LETS)
11. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
12. Familial thrombophilia: A complex genetic disorder
13. Inherited thrombophilic states
14. Thrombophilia as a multigenic disorder
15. Thrombosis in a patient with combined homozygosity for the factor V Leiden mutation and a mutation in the 3′-untranslated region of the prothrombin gene
16. 506 carriers in relationship to the presence or absence of juvenile venous thromboembolism
17. Resistance to activated protein C: Comparison of three different PCR methods for detection of FV R506Q
18. Factor V R506Q gene mutation analysis by PCR-RFLP. Optimization, comparison with functional testing for resistance to activated protein C, and establishment of cell line controls
19. Avoiding false-positives with PCR
20. Factor V Leiden detection in patients presenting with thrombotic episodes: Clinical characteristics
21. Prevalence and patient profile in activated protein C resistance
22. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
23. Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation
24. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism
25. 506 → Gln mutation in the gene for factor V (factor V Leiden)
26. Probability of recurrence of thrombosis in patients with and without factor V Leiden
27. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden
28. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene
29. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes
30. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment
31. Coexistence of factor V Leiden and factor II A20210 mutations and recurrent thromboembolism
32. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium